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Abstract
Purpose Humans have a preference for nasal breathing during sleep. This 10-year prospective study aimed to determine if nasal
symptoms can predict snoring and also if snoring can predict development of nasal symptoms. The hypothesis proposed is that
nasal symptoms affect the risk of snoring 10 years later, whereas snoring does not increase the risk of developing nasal
symptoms.
Methods In the cohort study, Respiratory Health in Northern Europe (RHINE), a random population from Denmark, Estonia,
Iceland, Norway, and Sweden, born between 1945 and 1973, was investigated by postal questionnaires in 1999–2001 (RHINE II,
baseline) and in 2010–2012 (RHINE III, follow-up). The study population consisted of the participants who had answered
questions on nasal symptoms such as nasal obstruction, discharge, and sneezing, and also snoring both at baseline and at
follow-up (n = 10,112).
Results Nasal symptoms were frequent, reported by 48% of the entire population at baseline, with snoring reported by 24%.
Nasal symptoms at baseline increased the risk of snoring at follow-up (adj. OR 1.38; 95% CI 1.22–1.58) after adjusting for age,
sex, BMI change between baseline and follow-up, and smoking status. Snoring at baseline was associated with an increased risk
of developing nasal symptoms at follow-up (adj. OR 1.22; 95% CI 1.02–1.47).
Conclusion Nasal symptoms are independent risk factors for development of snoring 10 years later, and surprisingly, snoring is a
risk factor for the development of nasal symptoms.
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Healthy people breathe predominantly through the nose dur-
ing sleep, and the resistance is lower than when breathing
through the mouth [1]. Nasal breathing also has other advan-
tages such as better ventilation compared to oral breathing [2].
Nasal symptoms such as obstruction can be a reason for pro-
motion of an opening of the mouth. In patients with nasal
obstruction, snoring is more frequent during nasal breathing
than oral breathing [3], while apnoeas in patients
with obstructive sleep apnoea (OSA) are more frequent during
oral breathing than during nasal breathing [1]. In OSA, pa-
tients often breathe through the mouth during sleep [4]. An
interesting pathophysiological question is whether or not there
is a switch from nasal to oral breathing in the process where
snoring and, later, OSA develop [5]. A few studies focus on
aspects on the question. It has been shown in a cross-sectional
study that nasal symptoms (nasal congestion, stuffy nose,
sneezing, blocked nose, loss of smell, facial pain or sinus
pressure, sore throat or hoarseness, and postnasal drip) in-
creased the odds of having OSA [6]. It has also been described
in a 5-year follow-up study (n = 4916) [7] that nocturnal nasal
obstruction was a risk factor for snoring. It is not known if the
direction of the association can be reversed; no studies have
been located in the literature investigating the question.
In the current study, the aim was to investigate if nasal
symptoms increase the risk of developing snoring and if snor-
ing is a risk factor for the induction of nasal symptoms. The
hypothesis proposed was that nasal symptoms have an impact
on the risk of developing snoring, whereas snoring does not
increase the risk of developing nasal symptoms.
Material and methods
Study design and study sample inclusive ethics
This is an epidemiological study of a random population born
between 1945 and 1973. The original cohort was part of the
European Community Respiratory Health Survey (ECRHS)
[8] stage I (www.ecrh.org). In a collaboration between the
Northern European countries Denmark, Estonia, Iceland,
Norway, and Sweden, a cohort called Respiratory Health in
Northern Europe (RHINE) was developed (www.rhine.nu).
The project is ongoing, and the cohort has been investigated
at three different occasions so far, 1991–1993 (RHINE I),
1999–2001 (RHINE II), and 2010–2012 (RHINE III).
Response rates at the different times have been described by
Johannessen et al. [9]. The current study population consists
of RHINE II (baseline) and RHINE III (follow-up) with the
participants who answered questions on rhinitis and snoring at
baseline and at follow-up. Patients without an answer to the
questions on rhinitis and snoring at both baseline and follow-
up were excluded from the analysis. The study population
(n = 10,112) is outlined in Fig. 1.
All participants completed written informed consent at
baseline and at follow-up. The local ethical committees at all
sites of the study have approved the project.
Definitions
The study participants were asked if they had loud and disturbing
snoring,with the response alternatives being “Never”, “Less than
once a week”, “Once or twice a week”, “Three to five nights/
days a week”, or “Almost every night/day”. Having snoring was
defined by reporting snoring ≥ 3/week. Having nasal symptoms
was defined by two questions combined. The first question (1)
was at baseline and at follow-up: answering “yes” to the question
“Have you ever had nasal discomfort like nasal obstruction,
nasal discharge and/or sneezing without having a cold?”. The
second question (2) was on seasonal nasal symptoms and was
investigated with the question “In which season are your symp-
toms the worst?” (Choose one alternative: “Spring”, Summer”,
“Autumn”, “Winter”, “Always”, and “I do not know”). Having
Fig. 1 Flowchart overview of the study sample (n = 10,112)
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nasal symptoms were considered with the answer “Always” in
question (2) as well as answering “yes” to question (1).
Self-reported weight and height were used to calculate
body mass index (BMI) by the formula weight/(height in
m)2, and the change in diff-BMI (Δ-BMI) was calculated by
BMI at follow-up subtracted by BMI at baseline. The ques-
tions investigating smoking history were “Are you a smoker?”
and “Are you an ex-smoker?”. In questions on comorbidity
(i.e. cardiovascular and diabetes mellitus), the response alter-
natives were “Yes” or “No”.
Sleep apnoea was examined at follow-up with the ques-
tions “Have you ever been diagnosed with sleep apnoea by a
doctor?” and “In what year were you diagnosed with sleep
apnoea?”. Having OSA required being diagnosed at least
1 year prior to answering the questionnaire. If the study par-
ticipants had been diagnosed prior to 1999 (baseline), they
were considered having OSA at baseline.
Data analysis (statistics)
Nominal data are presented as frequencies and percentages
without decimals. Ordinal and quantitative data are presented
bymean and standard deviation (mean ± SD). Non-parametric
statistics were used to compare the differences between
groups. The chi-square test was used in comparisons be-
tween nominal data in independent groups. The Mann–
Whitney U test was used in two independent group com-
parisons of ordinal and quantitative data, and the Wilcoxon
signed rank test was used when calculating paired group
differences for 2 groups. Spearman’s rank correlation (rs)
was used when measuring associations. In the binominal
logistic regression analysis, the Enter method was used,
which includes all predictors in the model. The statistical
software used was SPSS 25.0 and STATA version 15.
Results
Study sample
The study sample (n = 10,112) is outlined in the flow chart in
Fig. 1. Nasal symptoms were common; at baseline, 48% (n =
4903) of the study participants had nasal symptoms and 24%
(n = 2435) reported snoring. General information about the
participants is shown in Table 1. The mean age was 40.8 (±
7.2) years at baseline, 54% were women.
In Fig. 2, a Venn diagram shows the relationship between
nasal symptoms and snoring at baseline and at follow-up. A
large proportion of the patients with nasal symptoms also
reported snoring.
After 10 years, there was an increase in the number of
participants who reported snoring but no significant increase
in nasal symptoms (Fig. 3).
Among the group that did not have nasal symptoms at
baseline (n = 5273), new-onset nasal symptoms were reported
by 1301 participants.
Table 1 General information about the participants. Characteristics at baseline in patients with either nasal symptoms or snoring at follow-up. At
baseline, a high proportion of the study participants (n = 4903) reported nasal symptoms, and snoring was reported by 2435 participants
Baseline All Nasal symptoms (at follow-up) p Snoring (at follow-up) p
n=10,112 No, n=4903 Yes, n=5209 No, n=7608 Yes, n=2504
Age, mean ± SD 40.8±7.2 41.0±7.3 40.6±7.2 <0.001 40.4±7.3 41.8±6.9 <0.001
Sex (female) 54% 52% 57% <0.001 59% 38% <0.001
BMI1 mean ± SD 24.6±4.0 24.7±4.1 24.6±4.0 0.08 24.2±3.9 26.1±4.1 <0.001
Smoking
Never 25% 25% 26% 0.2 23% 31% <0.001
Previous 47% 48% 46% 49% 40%
Current 25% 25% 26% 26% 27%
Asthma 7% 2% 11% <0.001 6% 9% <0.001
Hay fever 24% 7% 41% <0.001 23% 25% 0.04
Nasal symptoms 48% 25% 72% <0.001 46% 53% <0.001
Snoring 18% 16% 19% <0.001 9% 47% <0.001
Sleep apnoea 1% 1% 1% 0.6 0.5% 2% <0.001
n-GER2 7% 6% 9% <0.001 6% 11% <0.001
1BMI, body mass index
2 n-GER, nocturnal gastric oesophageal reflux
Significance in italics
Numbers given as mean ± standard deviation (SD) or as %
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There was an increased risk of snoring at follow-up if nasal
symptoms were present at baseline. The risk was increased by
38% compared to the group with no nasal symptoms at base-
line. In a sensitivity analysis, with patients with OSA (n = 69)
at baseline excluded, the unadjusted odds ratio (95% CI) for
snoring was 1.37 (1.22–1.55).
For the patients who did not report snoring at baseline (n =
8308), snoring was reported by n = 1302 at follow-up. There
was a 22% increased risk of new-onset nasal obstruction at
follow-up if the participants reported snoring at baseline, see
Table 3. When adjusted for the same variables as in Table 2,
the odds ratio (95% CI) was 1.22 (1.04–1.49). In a sensitivity
analysis, with patients with OSA at baseline excluded, the
unadjusted odds ratio (95% CI) for nasal obstruction was
1.15 (0.97–1.37). When only including participants with nasal
symptoms at baseline, snoring at baseline had an OR of 0.85
(95% CI 0.73–0.99) for nasal symptoms resolving at follow-
up, and when controlling for the same variables as in Table 3,
the adjusted OR was 0.86 (95% CI 0.23–1.01).
Discussion
In this large longitudinal population study, the main findings
are that nasal symptoms are risk factors for snoring and snor-
ing on the other hand is also an independent risk factor for the
development of nasal symptoms.
Nasal symptoms are common and increase the risk
of snoring
In the current study, almost half of the study subjects re-
ported nasal symptoms at baseline, which is a similar num-
ber compared to 40% previously described by Hellgren
et al. [10]. Nasal symptoms are common in the general
population.
The current study shows that nasal symptoms increase the
risk of snoring 10 years later.
The finding is in line with a previous epidemiological study
by Young et al. [7] that found an increased risk of snoring
5 years after investigating nasal symptoms using a question-
naire at baseline. Very few recent studies investigate the rela-
tionship between nasal symptoms and snoring. One experimen-
tal study from 1991 [11] (n = 370) found that nasal airflow
resistance before and after decongestant was a predictor of
snoring index (snores per hour). One study by Virkkula [12]
found (n = 37) a relationship between the combination of nasal
obstruction and smoking and snoring but not for nasal obstruc-
tion alone. There are a small number of studies on treatment of
nasal obstruction and effect on snoring. Koutsourelakis et al.
[13] found an improvement in snoring frequency after treating
nasal obstruction with nasal steroids. Surgical treatment of the
nose has been tried to resolve snoring, but a review by Bury
and Singh [14] concluded that while quality of life can be
improved, the snoring is not cured. Positional therapy, weight
loss, andmandibular advancement device have been concluded
efficient in their review. These studies are focusing on other
issues than the questions asked in the current study.
The relation between nasal symptoms and snoring is not
thoroughly studied, but it is possible that having impaired
nasal breathing will make the individual gradually sleep with
the mouth open to compensate for the blocked nasal breathing.
With mouth breathing, the person may start snoring more than
when previously breathing through the nose while sleeping.
Snoring increase the risk of nasal symptoms
On the other hand, it was surprising and opposite to our hy-
pothesis that snoring increased the risk of nasal symptoms.
To our knowledge, no other study has shown that snoring
can increase the risk of nasal symptoms. In a recent review on
snoring [15], nasal symptoms were not mentioned among
consequences from snoring.
n = 974 n = 1804 
Total nasal symptoms  





n = 1329 n = 1106 
Total snoring 
n = 2435
Total nasal symptoms  
n = 4903 
n = 3574 
n = 3865 
Fig. 2 Proportions of patients with different symptoms at baseline and
follow-up. Venn diagram showing the proportions of patients with nasal
symptoms (orange), snoring (blue), and the combination of both nasal
symptoms and snoring (green) at baseline. No snoring and no nasal
symptoms were reported by n = 4353 at baseline. The next Venn diagram
shows the same groups at follow-up
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It is interesting to speculate on possible explanations on the
reasons for the worsening of the nasal symptoms in patients
with snoring at baseline. In patients who have undergone lar-
yngectomy and no longer use their nose at all, an objective
decrease in nasal dimensions has been shown after 1 year [16].
It is possible that a subgroup of snorers is oral breathers de-
spite normal nasal breathing, and years of low percentage of
nasal breathing induce obstruction.
An inflammatory response has been shown in patients with
OSA [17]. It could be speculated that an alternative explanation
for the development of nasal obstruction in snorers is an in-
flammatory response in the airways as well as in the nose. On
the other hand, a study by Liang Sun et al. [18] showed no
relationship between increased biomarkers of inflammation
and snoring, after controlling for BMI and waist circumference.
Strengths and limitations
Major strengths of the current study are that the cohort is large
and well described and the study participants included are
living in five different countries.
The question at RHINE II defining nasal symptoms is a
question asking if the patient has experienced nasal obstruc-
tion, nasal discharge, and/or sneezing. The patient can be
experiencing only one of the symptoms and still answer
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p = 0.4 
Fig. 3 A comparison of nasal
symptoms, snoring, and OSA at
baseline vs. follow-up. OSA
defined as diagnosed by a doctor
and with a year of diagnosis.
There was an increase in snoring
(p < 0.001) and in OSA
(p < 0.001)
Table 3 Odds ratio of new-onset
nasal symptoms if snoring at
baseline. Odds ratio of new-onset
nasal symptoms at follow-up
among participants with snoring
at baseline was increased with
22% compared to the group with
no nasal symptoms at baseline.
All patients with nasal symptoms





Snoring at baseline 1.16 (0.98–1.38) 1.22 (1.02–1.47)
Age 0.99 (0.98–1.00) 0.97 (0.97–0.99)
Age (38–49.9) (reference category) 1 1
Age (50–59.9) (reference category (38–49.9) 0.92 (0.81–1.06) 1.27 (1.05–1.53)
Age (60–67) (reference category (38–49.9) 0.83 (0.69–0.97) 1.13 (0.93–1.37)
Sex (female) 1.17 (1.03–1.32) 1.22 (1.07–1.40)
Δ-BMI 1.04 (1.01–1.06) 1.03 (1.01–1.06)
Smoking previous 1.17 (1.00–1.36) 1.13 (0.98–1.29)
Smoking current 1.39 (1.19–1.61) 1.39 (1.19–1.63)
CI, confidence interval
Nasal symptoms defined as always having obstruction, nasal discharge, and/or sneezing without having a cold
Significance in italics. Multiple regression analysis was used
Odds ratio adjusted for sex, age, Δ-BMI, and previous and current smoking (difference in body mass index
between baseline and follow-up)
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but not a true rhinitis. According to Young et al. [7], only 39%
of cases where severe nasal obstruction is maintained after
5 years are observed, and the validity is poor in determining
the presence or absence of nasal obstruction. Even though in
this study the number is 63%, there is a concern on whether it
is valid to see a person who described nasal obstruction after
10 years of follow-up as a new-onset nasal symptom in a
patient without nasal obstruction at baseline. This is an epide-
miological study with limitations enclosed in the study meth-
od. There are no objective measures on the nasal symptoms or
on the snoring or the occurrence of OSA. However, in a large
cohort like this, tendencies can be evaluated to be investigated
further in studies with other designs.
Clinical implications
Snoring is common and is associated with the potential of
reducing quality of sleep in patients and their bed partners.
Snoring can also be the first step towards developing OSA.
An understanding of the pathophysiology of OSA is im-
portant to enable possible prevention of the development of
the disease in the future.
It is important for general practitioners and ear, nose, and
throat doctors as well as rhinologists to be aware of the risk of
the development of nasal symptomswhen patients are snorers.
Doctors meeting patients with nasal problems should focus on
quality of sleep as well as symptoms from the nose. With this
knowledge, it is important to further investigate the relation-
ship between nasal symptoms and snoring and thus prevent
the development of future complications.
Conclusions
Nasal symptoms are independent risk factors for the develop-
ment of snoring, and snoring is a risk factor for the develop-
ment of nasal symptoms.
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